148
Views
3
CrossRef citations to date
0
Altmetric
Technology Evaluation

Proprietary Rel-Ease™ drug delivery technology: opportunity for sustained delivery of peptides, proteins and small molecules

, , , &
Pages 663-675 | Published online: 01 Sep 2006

Bibliography

  • PATTON JS, PLATZ RM: Pulmonary delivery of peptides and proteins for systemic action. Adv. Drug Del. Rev. (1992) 8:179-228.
  • SAGE BH Jr: Protein Delivery: Physical Systems. LM Sanders, RW Hendren (Eds), Plenum Press, New York, NY, USA (1997):319-341.
  • LEE VH: Non-oral routes of peptide and protein drug delivery. In: Peptide and Protein Drug Delivery. VH Lee (Ed.), Marcel Dekker, Inc., New York, NY, USA (1991):2-11.
  • WHITAKER MJ, HAO J, DAVIES OR et al.: The production of protein-loaded microparticles by supercritical fluid enhanced mixing and spraying. J. Control. Release (2005) 101(1-3):85-92.
  • SEELY JE, BUCKEL SD, GREEN PD et al.: Purification and analysis of pegylated protein pharmaceuticals presents many challenges. BioPharm International (2005) March issue.
  • ELVASSORE A, BERTUCCO A, CALICETI P: Production of protein-loaded polymeric microcapsules by compressed CO2 in a mixed solvent. Ind. Eng. Chem. Res. (2001) 40:795-800.
  • MONGIAT-ARTUS P, TEILLAC P: Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer. Expert Opin. Pharmacother. (2004) 5(10):2171-2179.
  • PARK JM, MUHOBERAC BB et al.: Effects of protein charge heterogeneity in protein-polyelectrolyte complexation. Macromolecules (1992) 25:290-295.
  • MATTISON KW, DUBIN PL et al.: Complex formation between bovine serum albumin and strong polyelectrolytes: effect of polymer charge density. J. Phys. Chem. B (1998) 102:3830-3836.
  • XU LC, LOGAN BE: Interaction forces measured using AFM between colloids and surfaces coated with both dextran and protein. Langmuir (2006) 22:4720-4727.
  • SATO T, MATTISON KW et al.: Effect of protein aggregation on the binding of lysozyme to pyrene-labeled polyanions. Langmuir (1998) 14:5430-5437.
  • XIA J, DUBIN PL et al.: Electrophoretic and quasi-elastic light scattering of soluble protein-polyelectrolyte complexes. J. Phys. Chem. B (1993) 97:4528-4534.
  • CERNASEV A, GROVES MJ: Evaluation of chitosan/anionic polymers as drug delivery systems. Drug Deliv. Technol. (2006) 6(4):28-35.
  • MI FL, HER NL et al.: Chitosan tablets for controlled release of theophylline: effect of polymer-drug wet or dry blending and anionic-cationic interpolymer complex. J. Appl. Polym. Sci. (1997) 66(13):2495-2505.
  • OWENS DR, BOLLI GB, ZINMAN B: Future options for insulin therapy. Current Science (2002) 83(12):1548-1555.
  • DE S, ROBINSON DH: Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing bodipy. AAPS Pharm. Sci. Tech. (2004) 5(4):e53.
  • WONG SL, LAU DT, BAUGHMAN SA et al.: Pharmacokinetics and pharmacodynamics of a novel depot formulation of abarelix, a gonadotropin-releasing hormone (GnRH) antagonist, in healthy men ages 50 to 75. J. Clin. Pharmacol. (2004) 44(5):495-502.
  • PATTERSON DL, YUNGINGER JW et al.: Anaphylaxis induced by the carboxymethylcellulose component of injectable triamcinolone acetonide suspension (Kenalog). Ann. Allergy Asthma Immunol. (1995) 74(2):163-166.
  • YI SHI, LUK CHIU LI: Current advances in sustained release systems for parenteral drug delivery. Expert Opin. Drug Deliv. (2005) 2(6):1039-1058.
  • CLELAND JL: Protein delivery from biodegradable microspheres. Pharm Biotechnol. (1997) 10:1-43.
  • PALAKODATY S, WALKER SE, TOWNEND G, YORK P: Particle engineering for drug delivery using supercritical fluid technologies. Life Science Today (2001) February 10 – 11.
  • CLELAND JL, JOHNSON OL, PUTNEY S et al.: Recombinant human growth hormone poly(lactic-co-glycolic acid) microshere formulation development. Adv. Drug Del. Rev. (1997) 28:71-84.
  • REDDY K, WRIGHT TL, POCKROS PJ: Efficacy and safety of pegylated (40 KD) interferon α2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C. Hepatology (2001) 33:433-438.
  • WANG YS, YOUNGSTER S, GRACE M et al.: Structural and biological characterization of pegylated recombinant interferon α-2b and its therapeutic implications. Adv. Drug Del. Rev. (2002) 54:547-570.
  • VERONESE FM: Peptide and protein pegylation: a review of problems and solutions. Biomaterials (2001) 22:405-417.
  • ESPOSITO P, BARBERO L, CACCIA P et al.: Pegylation of growth hormone-releasing hormone (GRF) analogues. Adv. Drug Del. Rev. (2003) 55(10):1279-1291.

Patents

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.